Onyx Therapeutics, Inc.

Hansen Wong

Christopher J Kirk

Naveen Bejugam

Tony Muchamuel

Mouhannad Jumaa

Rahul Vishram Manek

Sanjeev Sharma

This disclosure features modified release pharmaceutical formulations (e.g., extended release pharmaceutical formulations; e.g., solid dosage forms, e.g., tablets) that are useful for the oral administration of oprozomib, or a pharmaceutically acceptable salt thereof, to a human or animal subject as well as methods of making and using the formulations.

Growing community of inventors

San Mateo, CA, United States of America

Hansen Wong